Skip to main content
SpringerLink
Log in

Mast cells express CYP27A1 and CYP27B1 in epithelial skin cancers and psoriasis

  • Investigative Report
  • Published:
European Journal of Dermatology

Abstract

Background

Ultraviolet (UV) radiation and the vitamin D system are involved in immunosuppression in the skin. Previous in vitro and animal studies suggest a role for mast cells in these mechanisms.

Objective

To study vitamin D3 metabolizing enzymes, CYP27A1 and CYP27B1, in mast cells in epithelial skin cancers and psoriasis.

Materials and Methods

Biopsies were collected from the non-lesional and lesional skin of patients with actinic keratosis (AK), Bowen’s disease/squamous cell carcinoma (SCC), basal cell carcinoma (BCC) and psoriasis. CYP27A1 and CYP27B1 in mast cells were analysed using a sequential double-staining method.

Results

The percentage of mast cells containing CYP27A1 was significantly higher in lesional than non-lesional skin in all diseases, especially in SCC and BCC. In addition, the percentage of mast cells containing CYP27B1 was significantly increased in BCC, AK, and psoriatic lesions as well. Interestingly, only about 5-6% and 2% of the mast cells expressed CYP27A1 and CYP27B1, respectively, in the non-lesional skin of psoriatic and AK patients. In contrast, 23-38% and 6-9% of the mast cells were immunopositive for CYP27A1 and CYP27B1, respectively, in the non-lesional skin of BCC and SCC patients. In human LAD2 mast cell cultures, about 30% and 15% of the mast cells showed CYP27A1 and CYP27B1, respectively, though the immunostainings of these enzymes were not markedly affected by UVB irradiation.

Conclusions

Increased proportions of mast cells express vitamin D3 metabolizing enzymes in the lesional skin. Therefore, mast cells may promote an immunosuppressive environment, e.g., in skin carcinoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Böni R, Schuster C, Nehrhoff B, Burg G. Epidemiology of skin cancer. Neuro Endocrinol Lett 2002; 23(Suppl 2): 48–51.

    PubMed  Google Scholar 

  2. Goruppi S, Paolo Dotti G. Mesenchymal stroma: primary determinant and therapeutic target for epithelial cancer. Trends Cell Biol 2013; 23: 593–602.

    Article  CAS  PubMed  Google Scholar 

  3. Furue M. Epithelial tumor, invasion and stroma. Ann Dermatol 2011; 23: 125–31.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Ch’ng S, Wallis RA, Yuan L, Davis PF, Tan ST. Mast cells and cutaneous malignancies. Mod Pathol 2006; 19: 149–59.

    Article  PubMed  Google Scholar 

  5. Kempf W, Mertz KD, Hofbauer GF, Tinguely M. Skin cancer in organ transplant recipients. Pathobiology 2013; 80: 302–9.

    Article  PubMed  Google Scholar 

  6. Harvima IT, Nilsson G. Mast cells as regulators of skin inflammation and immunity. Acta Derm Venereol 2011; 91: 644–50.

    Article  PubMed  Google Scholar 

  7. Lehmann B. The vitamin D3 pathway in human skin and its role for regulation of biological processes. Photochem Photobiol 2005; 81: 1246–51.

    Article  CAS  PubMed  Google Scholar 

  8. Tang JY, Fu T, Lau C, Oh DH, Bikle DD, Asgari MM. Vitamin D in cutaneous carcinogenesis. J Am Acad Dermatol 2012; 67, 817.e1-11.

  9. Rodrigo Mora J, Iwata M, von Andrian UH. Vitamin effects on the immune system: vitamins A and D take centre stage. Nat Rev Immunol 2008; 8: 685–98.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Biggs L, Yu C, Fedoric B, Lopez AF, Galli SJ, Grimbaldeston MA. Evidence that vitamin D3 promotes mast-cell dependent reduction of chronic UVB-induced skin pathology in mice. J Exp Med 2010; 207: 455–63.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Yu C, Fedoric B, Anderson PH, Lopez AF, Grimbaldeston MA. Vitamin D3 signalling to mast cells: a new regulatory axis. Int J Biochem Cell Biol 2011; 43: 41–6.

    Article  CAS  PubMed  Google Scholar 

  12. Yip KH, Kolesnikoff N, Yu C, et al. Mechanisms of vitamin D3 metabolite repression of IgE-dependent mast cell activation. J Allergy Clin Immunol 2014; 133: 1356–64.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Lou Y-R, Molnár F, Peräkylä M, et al. 25-Hydroxyvitamin D3 is an agonistic vitamin D receptor ligand. J Steroid Biochem Mol Biol 2010; 118: 162–70.

    Article  CAS  PubMed  Google Scholar 

  14. Gottfried E, Rehli M, Hahn J, Holler E, Andreesen R, Kreutz M. Monocyte-derived cells express CYP27A1 and convert vitamin D3 into its active metabolite. Biochem Biophys Res Commun 2006; 349: 209–13.

    Article  CAS  PubMed  Google Scholar 

  15. Mitschele T, Diesel B, Friedrich M, et al. Analysis of the vitamin D system in basal cell carcinomas (BCCs). Lab Invest 2004; 84: 693–702.

    Article  CAS  PubMed  Google Scholar 

  16. Reichrath J, Rafi L, Rech M, et al. Analysis of the vitamin D system in cutaneous squamous cell carcinomas. J Cutan Pathol 2004; 31: 224–31.

    Article  PubMed  Google Scholar 

  17. Suttle MM, Nilsson G, Snellman E, Harvima IT. Experimentally induced psoriatic lesion associates with interleukin (IL)-6 in mast cells and appearance of dermal cells expressing IL-33 and IL-6 receptor. Clin Exp Immunol 2012; 169: 311–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Ackermann L, Harvima IT, Pelkonen J, et al. Mast cells in psoriatic skin are strongly positive for interferon-gamma. Br J Dermatol 1999; 140: 624–33.

    Article  CAS  PubMed  Google Scholar 

  19. Kirshenbaum AS, Akin C, Wu Y, et al. Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 established from a patient with mast cell sarcoma/leukemia; activation following aggregation of FcepsilonRI or FcgammaRI. Leuk Res 2003; 27: 677–82.

    Article  CAS  PubMed  Google Scholar 

  20. Ilves T, Harvima IT. OX40 ligand and OX40 are increased in atopic dermatitis lesions but do not correlate with clinical severity. J Eur Acad Dermatol Venereol 2013; 27: e197-205.

    Article  Google Scholar 

  21. Babina M, Krautheim M, Grützkau A, Henz BM. Human leukemic (HMC-1) mast cells are responsive to 1α,25-dihydroxyvitamin D3: selective promotion of ICAM-3 expression and constitutive presence of vitamin D3 receptor. Biochem Biophys Res Commun 2000; 273: 1104–10.

    Article  CAS  PubMed  Google Scholar 

  22. Araya Z, Tang W, Wikvall K. Hormonal regulation of the human sterol 27-hydroxylase gene CYP27A1. Biochem J 2003; 372: 529–34.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Hansson M, Wikvall K, Babiker A. Regulation of sterol 27-hydroxylase in human monocyte-derived macrophages: upregulation by transforming growth factor β1. Biochim Biophys Acta 2005; 1687: 44–51.

    Article  CAS  PubMed  Google Scholar 

  24. Norlin M, Pettersson H, Tang W, Wikvall K. Androgen receptormediated regulation of the anti-atherogenic enzyme CYP27A1 involves JNK/c-junc pathway. Arch Biochem Biophys 2011; 506: 236–41.

    Article  CAS  PubMed  Google Scholar 

  25. Fu H, Wu C, Riaz H, et al. β-Cryptoxanthin uptake in THP-1 macrophages upregulates the CYP27A1 signaling pathway. Mol Nutr Food Res 2014; 58: 425–36.

    Article  CAS  PubMed  Google Scholar 

  26. Quinn CM, Jessup W, Wong J, Kritharides L, Brown AJ. Expression and regulation of sterol 27-hydroxylase (CYP27A1) in human macrophages: a role for RXR and PPARgamma ligands. Biochem J 2005; 385: 823–30.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Adams JS, Rafison B, Witzel S, et al. Regulation of the extrarenal CYP27B1-hydroxylase. J Steroid Biochem Mol Biol 2014; 144PA: 22–7.

    Article  PubMed Central  Google Scholar 

  28. Campbell GR, Spector SA. Toll-like receptor 8 ligands activate a vitamin D mediated autophagic response that inhibits human immunodeficiency virus type 1. PLoS Pathog 2012; 8: e1003017.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Klug-Micu GM, Stenger S, Sommer A, et al. CD40 ligand and interferon-induce an antimicrobial response against Mycobacterium tuberculosis in human monocytes. Immunology 2013; 139: 121–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Viaene L, Evenepoel P, Meijers B, Vanderschueren D, Overbergh L, Mathieu C. Uremia suppresses immune signal-induced CYP27B1 expression in human monocytes. Am J Nephrol 2012; 36: 497–508.

    Article  CAS  PubMed  Google Scholar 

  31. Mulligan JK, Nagel W, O’Connell BP, Wentzel J, Atkinson C, Schlosser RJ. Cigarette smoke exposure is associated with vitamin D3 deficiencies in patients with chronic rhinosinusitis. J Allergy Clin Immunol 2014; 134: 342–9.

    Article  CAS  PubMed  Google Scholar 

  32. Seifert M, Tilgen W, Reichrath J. Expression of 25-hydroxyvitamin D-1α-hydroxylase (1OHase, CYP27B1) splice variants in HaCaT keratinocytes and other skin cells: modulation by culture conditions and UV-B treatment in vitro. Anticancer Res 2009; 29: 3659–67.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, Kuopio University Hospital and University of Eastern Finland, P.O.B. 100, 70029, KYS Kuopio, Finland

    Antti Kaukinen & Ilkka T. Harvima

  2. Department of Clinical Microbiology, University of Eastern Finland, 70210, Kuopio, Finland

    Jukka Pelkonen

Authors
  1. Antti Kaukinen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jukka Pelkonen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ilkka T. Harvima
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ilkka T. Harvima.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kaukinen, A., Pelkonen, J. & Harvima, I.T. Mast cells express CYP27A1 and CYP27B1 in epithelial skin cancers and psoriasis. Eur J Dermatol 25, 548–555 (2015). https://doi.org/10.1684/ejd.2015.2645

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1684/ejd.2015.2645

Keywords

Search

Navigation